Current controversies on the clinical use of dipyrone: safe alternative?
2. Edwards J, Meseguer F, Faura C, et al. Single dose dipyrone for acute postoperative pain. Cochrane Database Syst Rev 2010;9: CD003227.
3. Gaertner J, Stamer UM, Remi C, et al. Metamizole/dipyrone for the relief of cancer pain: a systematic review and evidence-based recommendations for clinical practice. Palliat Med 2017;31:26-34.
4. Konijnenbelt-Peters J, Heijden C, Ekhart C, et al. Metamizole (dipyrone) as an alternative agent in postoperative analgesia in patients with contraindications for nonsteroidal anti-inflammatory drugs. Pain Pract 2017;17:402-408.
5. IAAAS Study GroupRisks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 1986;256:1749-1757.
6. Ibanez L, Vidal X, Ballarin E, et al. Agranulocytosis associated with dipyrone (metamizole). Eur J Clin Pharmacol 2005; 60:821-829.
7. Benjamin JE, Biederman JB. Agranulocytic leukopenia induced by a drug related to aminopyrine. JAMA 1934;103:161-163.
8. Arneborn P, Palmblad J. Drug-induced neutropenia-a survey for Stockholm 1973-1978. Acta Med Scand 1982;212:289-292.
9. Wong A. A reappraisal of antipyretic and analgesic drugs. WHO pharmaceuticals newsletter [Internet. [Cited September 10, 2019. Available at: http://apps.who.int/medicinedocs/en/d/Js2253e/5.html
10. CCIOMS Working Group IV Benefit-risk balance of marketed drugs: evaluating drug signals. Geneva: CIOMS; 1998.
11. Cashman JN, Dolin SJ. Respiratory and haemodynamic effects of acute postoperative pain management: evidence from published data. Br J Anaesth 2004;93:212-223.
12. Chin KK, Carroll I, Desai K, et al. Integrating adjuvant analgesics into perioperative pain practice: results from an academic medical center. Pain Med 2019;pnz053.